Artemis Investment Management LLP Has $17.62 Million Stake in Hamilton Lane Inc. (NASDAQ:HLNE)

Artemis Investment Management LLP decreased its holdings in Hamilton Lane Inc. (NASDAQ:HLNE - Free Report) by 42.2% in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 118,540 shares of the company's stock after selling 86,459 shares during the quarter. Artemis Investment Management LLP owned 0.21% of Hamilton Lane worth $17,623,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Vanguard Group Inc. increased its position in shares of Hamilton Lane by 28.4% during the 4th quarter. Vanguard Group Inc. now owns 3,901,933 shares of the company's stock worth $577,681,000 after purchasing an additional 863,326 shares in the last quarter. Invesco Ltd. increased its holdings in shares of Hamilton Lane by 25.3% during the fourth quarter. Invesco Ltd. now owns 1,923,253 shares of the company's stock worth $284,738,000 after buying an additional 388,019 shares in the last quarter. Price T Rowe Associates Inc. MD raised its stake in shares of Hamilton Lane by 229.7% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 1,292,266 shares of the company's stock valued at $191,321,000 after acquiring an additional 900,283 shares during the last quarter. Geode Capital Management LLC raised its stake in shares of Hamilton Lane by 4.1% in the fourth quarter. Geode Capital Management LLC now owns 1,149,928 shares of the company's stock valued at $170,280,000 after acquiring an additional 44,865 shares during the last quarter. Finally, T. Rowe Price Investment Management Inc. boosted its holdings in shares of Hamilton Lane by 10.0% in the 4th quarter. T. Rowe Price Investment Management Inc. now owns 780,363 shares of the company's stock worth $115,533,000 after acquiring an additional 70,976 shares in the last quarter. 97.40% of the stock is owned by institutional investors.

Hamilton Lane Trading Down 1.4%

Shares of Hamilton Lane stock traded down $2.02 on Monday, hitting $142.12. 619,572 shares of the company's stock traded hands, compared to its average volume of 507,989. The firm's 50-day moving average price is $153.70 and its two-hundred day moving average price is $151.55. The company has a debt-to-equity ratio of 0.31, a current ratio of 4.83 and a quick ratio of 4.83. The stock has a market capitalization of $7.61 billion, a PE ratio of 26.37 and a beta of 1.25. Hamilton Lane Inc. has a one year low of $120.86 and a one year high of $210.00.

Hamilton Lane (NASDAQ:HLNE - Get Free Report) last released its quarterly earnings data on Thursday, May 29th. The company reported $1.21 EPS for the quarter, beating analysts' consensus estimates of $1.20 by $0.01. Hamilton Lane had a return on equity of 32.94% and a net margin of 30.50%. The business had revenue of $197.97 million during the quarter, compared to the consensus estimate of $165.49 million. During the same quarter in the prior year, the company posted $1.38 earnings per share. The firm's revenue was up 12.1% on a year-over-year basis. On average, research analysts expect that Hamilton Lane Inc. will post 4.97 EPS for the current fiscal year.

Hamilton Lane Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, July 7th. Investors of record on Friday, June 20th will be given a $0.54 dividend. This represents a $2.16 dividend on an annualized basis and a dividend yield of 1.52%. This is an increase from Hamilton Lane's previous quarterly dividend of $0.49. The ex-dividend date is Friday, June 20th. Hamilton Lane's dividend payout ratio (DPR) is currently 40.07%.

Analyst Upgrades and Downgrades

A number of brokerages have recently weighed in on HLNE. Wall Street Zen lowered Hamilton Lane from a "hold" rating to a "sell" rating in a research note on Friday, June 6th. Morgan Stanley dropped their target price on shares of Hamilton Lane from $190.00 to $157.00 and set an "equal weight" rating for the company in a research note on Monday, April 14th. JPMorgan Chase & Co. decreased their price target on shares of Hamilton Lane from $176.00 to $167.00 and set a "neutral" rating on the stock in a research note on Tuesday, April 29th. Oppenheimer lowered shares of Hamilton Lane from an "outperform" rating to a "market perform" rating in a report on Thursday, May 15th. Finally, Keefe, Bruyette & Woods dropped their price objective on shares of Hamilton Lane from $162.00 to $155.00 and set a "market perform" rating for the company in a research report on Monday, June 2nd. Two equities research analysts have rated the stock with a sell rating and six have given a hold rating to the stock. Based on data from MarketBeat.com, Hamilton Lane currently has a consensus rating of "Hold" and an average price target of $164.29.

Hamilton Lane Profile

Hamilton Lane Incorporated is a private equity firm specializing in early venture, emerging growth, turnaround, middle market, mature, mid-venture, bridge, buyout, distressed/vulture, loan, mezzanine in growth capital companies. It prefers to invest in energy, industrials, consumer discretionary, health care, real estate, information technology, utilities, and consumer services.